Literature DB >> 12064004

Successful treatment of a T1 cancer of the pancreatic head with high dose rate brachytherapy and external radiotherapy.

Zoltán Takácsi-Nagy1, János Varga, Imre Poller, János Fodor, Csaba Polgár, Agota Petrányi, Tibor Major, György Németh.   

Abstract

In this report, a unique case of a localized (T1N0M0) adenocarcinoma of the head of the pancreas is presented, which was successfully treated with interstitial high dose rate brachytherapy combined with percutan irradiation after biopsy. A total dose of 18 Gy was delivered with brachytherapy (6 Gy per fraction on three consecutive days) to the tumor via after-loading catheter. Brachytherapy was followed by external radiotherapy, delivering an additional dose of 46 Gy (18 MV-x) with four-field technique using conventional fractionation (2 Gy/day). Thirty-six months after completion of the treatment the patient is alive with no evidence of disease. The combination of interstitial high dose rate brachytherapy and external beam radiation therapy may be an effective tool to deliver curative dose without any significant sequelae in the treatment of operable pancreatic carcinoma, when the patient's condition contraindicates surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12064004

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Endovascular implantation of iodine-125 seed strand combined and stent placement for locally advanced pancreatic ductal adenocarcinoma with vascular invasion: a prospective single-arm pilot study.

Authors:  Linlin Wu; Yanbo Zhang; Zihan Zhang; Fengfeng Li; Jianjun Luo
Journal:  J Contemp Brachytherapy       Date:  2020-10-30

Review 2.  Cryosurgery in combination with brachytherapy of iodine-125 seeds for pancreatic cancer.

Authors:  Kecheng Xu; Lizhi Niu; Feng Mu; Yize Hu
Journal:  Gland Surg       Date:  2013-05

Review 3.  Advances in cryoablation for pancreatic cancer.

Authors:  Xiao-Mei Luo; Li-Zhi Niu; Ji-Bing Chen; Ke-Cheng Xu
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

4.  Pilot trial of endoscopic ultrasound-guided interstitial chemoradiation of UICC-T4 pancreatic cancer.

Authors:  Siyu Sun; Nan Ge; Sheng Wang; Xiang Liu; Guoxin Wang; Jintao Guo
Journal:  Endosc Ultrasound       Date:  2012-04       Impact factor: 5.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.